Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07060794

Tafenoquine and ACTs (TADORE- Plus)

Status
Not Yet Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
507 (estimated)
Sponsor
Menzies School of Health Research · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A trial designed to determine whether there is a clinically significant drug-drug interaction of tafenoquine with DHA-piperaquine or artesunate-pyronaridine using a control arm with radical cure given at the end of follow up (delayed radical cure).

Conditions

Interventions

TypeNameDescription
DRUGTafenoquine plus DHA-PiperaquineTafenoquine plus DHA-piperaquine
DRUGTafenoquine plus Artesunate-pyronaridineTafenoquine plus Artesunate-pyronaridine

Timeline

Start date
2026-06-01
Primary completion
2028-06-01
Completion
2028-06-01
First posted
2025-07-11
Last updated
2026-03-18

Source: ClinicalTrials.gov record NCT07060794. Inclusion in this directory is not an endorsement.